1.
Br J Cancer
; 125(8): 1036-1038, 2021 10.
Artículo
en Inglés
| MEDLINE
| ID: mdl-33931744
RESUMEN
The advent of ctDNA has the potential to be a game changer in some cancers, but limited data is available in oesophago-gastric cancers (OGC). The prognostic value of ctDNA and the potential for false positive results due to clonal haematopoiesis of indeterminate potential (CHIP) was recently reported in operable OGC.